Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Microbiome composition contrasting probiosis/dysbiosis states in Cobia (Rachycentron canadum)

PROVIDER: PRJNA796496 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17578940.fastq.gz	Fastqsanger.gz
	SRR17578941.fastq.gz	Fastqsanger.gz
	SRR17578942.fastq.gz	Fastqsanger.gz
	SRR17578943.fastq.gz	Fastqsanger.gz
	SRR17578944.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 56

Similar Datasets

Rachycentron canadum

Project description:Rachycentron canadum overview

| PRJNA378312 | ENA

Project description:Gonadal Transcriptome Analysis of Sex-Related Genes in the Cobia (Rachycentron canadum)

| PRJNA853560 | ENA

Rachycentron canadum

Project description:Transcriptome profiling of Cobia (Rachycentron canadum) in response to Photobacteriumdamselae subsp. piscicida

| PRJNA377793 | ENA

Rachycentron canadum

Project description:De novo transcriptome assembly and functional annotation of cobia (Rachycentron canadum) liver

| PRJNA675281 | ENA

Effect of morphine treatment on microbiome in the context of microbial transplant.

Project description:Morphine causes microbial dysbiosis. In this study we focused on restoration of native microbiota in morphine treated mice and looked at the extent of restoration and immunological consequences of this restoration. Fecal transplant has been successfully used clinically, especially for treating C. difficile infection2528. With our expanding knowledge of the central role of microbiome in maintenance of host immune homeostasis17, fecal transplant is gaining importance as a therapy for indications resulting from microbial dysbiosis. There is a major difference between fecal transplant being used for the treatment of C. difficile infection and the conditions described in our studies. The former strategy is based on the argument that microbial dysbiosis caused by disproportionate overgrowth of a pathobiont can be out-competed by re-introducing the missing flora by way of a normal microbiome transplant. This strategy is independent of host factors and systemic effects on the microbial composition. Here, we show that microbial dysbiosis caused due to morphine can be reversed by transplantation of microbiota from the placebo-treated animals.

2016-06-01 | E-MTAB-3723 | biostudies-arrayexpress

Rachycentron canadum

Project description:Rachycentron canadum Genome sequencing

| PRJNA864890 | ENA

Opioid-induced gut microbial disruption leads to gut barrier compromise and sustained systemic inflammation.

Project description:Morphine and its pharmacological derivatives are the most prescribed analgesics for moderate to severe pain management. However, chronic use of morphine reduces pathogen clearance and induces bacterial translocation across the gut barrier. The enteric microbiome has been shown to play a critical role in the preservation of the mucosal barrier function and metabolic homeostasis. Here, we show for the first time, using bacterial 16s rDNA sequencing, that chronic morphine treatment significantly alters the gut microbial composition and induces preferential expansion of the gram-positive pathogenic and reduction of bile-deconjugating bacterial strains. A significant reduction in both primary and secondary bile acid levels was seen in the gut, but not in the liver with morphine treatment. Morphine induced microbial dysbiosis and gut barrier disruption was rescued by transplanting placebo-treated microbiota into morphine-treated animals, indicating that microbiome modulation could be exploited as a therapeutic strategy for patients using morphine for pain management. In this study, we establish a link between the two phenomena, namely gut barrier compromise and dysregulated bile acid metabolism. We show for the first time that morphine fosters significant gut microbial dysbiosis and disrupts cholesterol/bile acid metabolism. Changes in the gut microbial composition is strongly correlated to disruption in host inflammatory homeostasis13,14 and in many diseases (e.g. cancer/HIV infection), persistent inflammation is known to aid and promote the progression of the primary morbidity. We show here that chronic morphine, gut microbial dysbiosis, disruption of cholesterol/bile acid metabolism and gut inflammation; have a linear correlation. This opens up the prospect of devising minimally invasive adjunct treatment strategies involving microbiome and bile acid modulation and thus bringing down morphine-mediated inflammation in the host.

2016-06-01 | E-MTAB-3722 | biostudies-arrayexpress

Rachycentron canadum

Project description:Rachycentron canadum Genome sequencing and assembly

| PRJNA634421 | ENA

Rachycentron canadum

Project description:Rachycentron canadum Transcriptome or Gene expression

| PRJNA892299 | ENA

Rachycentron canadum

Project description:Rachycentron canadum Transcriptome or Gene expression

| PRJNA550021 | ENA